A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2
Acta Pharmaceutica Sinica B · 2026-02 · 16 (2) · 900-912
DOI: 10.1016/j.apsb.2025.11.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-02. Verfasst von Hanlu Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Suzhou 215126, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program of Guangzhou, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences, Peking Union Medical College, Suzhou 215126, China.
- Biopharmagen Corp., Suzhou 215126, China.
- Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Kunmi…
- Department of Lung Cancer Center and Center for Preclinical Safety Evaluation of Drugs, West China Hospital, Sichuan University, Chengdu 610041, China.
Förderung
- Key Technologies Research and Development Program of Guangzhou
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Science and Technology Program of Suzhou
- West China Hospital, Sichuan University
Zitieren
APA
Wang, H., Yang, T., Yan, Y., Yang, F., Song, X., Zhang, S., Jiang, W., Li, M., Sun, W., Li, Y., Jin, W., Duan, S., Qin, M., He, Z., & Jiang, Y. (2026). A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2. Acta Pharmaceutica Sinica B, 16(2), 900-912. https://doi.org/10.1016/j.apsb.2025.11.027
Vancouver
Wang H, Yang T, Yan Y, Yang F, Song X, Zhang S, et al. A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2. Acta Pharmaceutica Sinica B. 2026;16(2):900-912. doi:10.1016/j.apsb.2025.11.027
BibTeX
@article{Wang2026,
author = {Wang, Hanlu and Yang, Tiantian and Yan, Yichao and Yang, Fengmei and Song, Xunhuan and Zhang, Shuning and Jiang, Wenhong and Li, Mingxue and Sun, Wenting and Li, Yanyan and Jin, Weihua and Duan, Suqin and Qin, Meng and He, Zhanlong and Jiang, Yongping},
title = {A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {2},
pages = {900--912},
doi = {10.1016/j.apsb.2025.11.027}
}
EUVIMED